We are live on ! Find out more
ADPT icon

Adaptive Biotechnologies
ADPT

219 hedge funds and large institutions have $4B invested in Adaptive Biotechnologies in 2021 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 84 increasing their positions, 63 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

58% more call options, than puts

Call options by funds: $6.5M | Put options by funds: $4.11M

33% more repeat investments, than reductions

Existing positions increased: 84 | Existing positions reduced: 63

0.05% more ownership

Funds ownership: 83.68% → 83.73% (+0.05%)

5% less funds holding

Funds holding: 230 → 219 (-11)

16% less capital invested

Capital invested by funds: $4.8B → $4B (-$791M)

20% less funds holding in top 10

Funds holding in top 10: 5 → 4 (-1)

24% less first-time investments, than exits

New positions opened: 22 | Existing positions closed: 29

Holders
219
Holders Change
-11
Holders Change %
-4.78%
% of All Funds
3.83%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.07%
New
22
Increased
84
Reduced
63
Closed
29
Calls
$6.5M
Puts
$4.11M
Net Calls
+$2.39M
Net Calls Change
-$8.5M

Top Buyers

1
Vanguard Group
Vanguard Group
Pennsylvania
+$29.4M
2
AIM
ARK Investment Management
Florida
+$17.7M
3
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$17.3M
4
BG
Bellevue Group
Switzerland
+$13.5M
5
BlackRock
BlackRock
New York
+$9.78M

Top Sellers

1
SM
SB Management
United Arab Emirates
-$50.7M
2
RSCM
Rock Springs Capital Management
Maryland
-$26.6M
3
KCM
Kornitzer Capital Management
Kansas
-$15.8M
4
MCMC
Matrix Capital Management Company
New Hampshire
-$8.23M
5
ZCI
Zevenbergen Capital Investments
Washington
-$8.04M
Name Holding Trade Value Shares
Change 		Change in
Stake
ZCI
26
Zevenbergen Capital Investments
Washington
$27.4M -$8.04M -222,345 -22%
AAP
27
Aristotle Atlantic Partners
Florida
$24.7M +$350K +9,684 +1%
Ameriprise
28
Ameriprise
Minnesota
$19.7M +$1.71M +47,418 +9%
PAMS
29
Pictet Asset Management (Switzerland)
Switzerland
$19.6M +$20.9M +576,700 New
Thrivent Financial for Lutherans
30
Thrivent Financial for Lutherans
Minnesota
$19.1M +$509K +14,086 +3%
Northern Trust
31
Northern Trust
Illinois
$16.3M +$548K +15,154 +3%
Principal Financial Group
32
Principal Financial Group
Iowa
$16.1M +$436K +12,059 +3%
Morgan Stanley
33
Morgan Stanley
New York
$15.8M -$1.06M -29,194 -6%
Allianz Asset Management
34
Allianz Asset Management
Germany
$15.2M -$640K -17,694 -4%
EHI
35
Eagle Health Investments
Connecticut
$15M +$6.64M +183,639 +71%
BAMCO Inc
36
BAMCO Inc
New York
$12M -$4.34M -120,000 -25%
PA
37
Perceptive Advisors
New York
$12M – – –
N
38
Nuveen
North Carolina
$11.7M -$1.94M -53,523 -13%
TCM
39
Tekla Capital Management
Massachusetts
$11.5M – – –
DP
40
DDD Partners
Washington
$10.8M +$2.41M +66,545 +27%
PCM
41
Peregrine Capital Management
Minnesota
$9.43M -$1.61M -44,578 -14%
PVI
42
Pura Vida Investments
New York
$8.7M -$1.7M -47,116 -16%
William Blair & Company
43
William Blair & Company
Illinois
$8.61M -$930K -25,716 -9%
California Public Employees Retirement System
44
California Public Employees Retirement System
California
$7.45M +$176K +4,875 +2%
Dimensional Fund Advisors
45
Dimensional Fund Advisors
Texas
$7.12M +$3.02M +83,549 +66%
Primecap Management
46
Primecap Management
California
$6.99M -$506K -14,000 -6%
Swiss National Bank
47
Swiss National Bank
Switzerland
$6.85M +$76K +2,100 +1%
PC
48
Pier Capital
Connecticut
$6.71M -$79.7K -2,205 -1%
KCM
49
Kornitzer Capital Management
Kansas
$6.55M -$15.8M -436,405 -69%
Bank of America
50
Bank of America
North Carolina
$6.4M -$317K -8,753 -4%
1
2
3 4 5

ADPT Hedge Fund Activity: Q3 2021 in Review

219 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Adaptive Biotechnologies (ADPT) for Q3 2021, worth a combined $4B — down 16% from $4.8B a quarter earlier.

Sellers outnumbered buyers: 29 funds closed out of ADPT and 22 opened new positions — a net loss of 7 holders — while 63 trimmed existing stakes and 84 added.

The largest buyer was Vanguard Group, adding an estimated $29.4M. The largest seller was SB Management, exiting entirely with an estimated $50.7M sold.

  • 219 institutional investors held Adaptive Biotechnologies (ADPT) as of Q3 2021, down from 230 in Q2 2021.
  • Funds reported $4B of Adaptive Biotechnologies stock for Q3 2021, down 16% quarter-over-quarter.
  • 22 funds opened new Adaptive Biotechnologies positions in Q3 2021 and 29 closed out, a net change of -7 holders.
  • The largest Adaptive Biotechnologies buyer in Q3 2021 was Vanguard Group, an estimated $29.4M added.
  • The largest Adaptive Biotechnologies seller in Q3 2021 was SB Management, an estimated $50.7M sold.

Based on aggregated 13F filings for Q3 2021.